Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ICPT

Intercept Pharmaceuticals (ICPT) Stock Price, News & Analysis

Intercept Pharmaceuticals logo

About Intercept Pharmaceuticals Stock (NASDAQ:ICPT)

Advanced Chart

Key Stats

Today's Range
$19.00
$19.00
50-Day Range
$18.20
$19.00
52-Week Range
$8.82
$21.86
Volume
N/A
Average Volume
1.36 million shs
Market Capitalization
$794.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ICPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intercept Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ICPT Stock News Headlines

Trump's ticking time bomb
A looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House document might be the real trigger. One market expert who predicted major collapses in 2008 is now warning of a second, far more explosive directive tied to America’s most vital resource. If he’s right, it could set off a financial shock unlike anything we’ve seen in decades.
See More Headlines

ICPT Stock Analysis - Frequently Asked Questions

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) released its quarterly earnings results on Wednesday, August, 2nd. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.42. The firm's revenue was up 16.6% on a year-over-year basis.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intercept Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Sarepta Therapeutics (SRPT), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
8/02/2023
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ICPT
Employees
341
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$221.82 million
Pretax Margin
-18.09%

Debt

Sales & Book Value

Annual Sales
$285.71 million
Price / Cash Flow
N/A
Book Value
$1.72 per share
Price / Book
11.05

Miscellaneous

Free Float
39,192,000
Market Cap
$794.77 million
Optionable
Optionable
Beta
0.88

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ICPT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners